Thursday, June 5, 2025
VISIT ROYALMOK
Agarwood Times
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
Agarwood Times
No Result
View All Result

BARDA to fund development of COVID preventive drug

January 18, 2025
in Diseases
Reading Time: 2 mins read
0 0
A A
0
Home Diseases
Share on FacebookShare on Twitter


The Administration for Strategic Preparedness and Response (ASPR) introduced yesterday that it’s going to give drugmaker Shionogi, Inc, $375 million to develop a drug to forestall COVID-19 an infection in people who find themselves immune compromised.

The drug is a long-acting formulation of S-892216, a protease inhibitor that blocks the principle protease of SARS-CoV-2 and prevents the virus from making copies of itself in human cells. Designed for pre-exposure prophylaxis (prevention), it could be given to immune compromised folks, who could not mount an satisfactory immune response to vaccines, earlier than they’re uncovered to the virus.

Shionogi is receiving the funding from Mission NextGen, a $5 billion program led by ASPR’s Biomedical Superior Analysis and Growth Authority (BARDA) and the Nationwide Institute of Allergy and Infectious Illnesses.

“At BARDA, we will likely be working with Shionogi to speed up improvement of this preventative therapeutic to assist defend weak Individuals,” BARDA Director Gary Disbrow, PhD, mentioned in a press launch.

Shionogi plans to file an Investigational New Drug utility and start part 1 scientific trials this yr.

CARB-X funds peptide antibiotic

In different drug-development information, CARB-X (Combating Antibiotic-Resistant Micro organism Biopharmaceutical Accelerator) introduced yesterday that it’s awarding $610,000 to Justus Liebig College Giessen in Germany to develop a first-in-class peptide antibiotic.

The cash will assist researchers on the college outline a lead optimization path for a direct-acting peptide therapeutic that targets the BamA protein in gram-negative micro organism. BamA performs a essential function in constructing the outer membrane of gram-negative pathogens, which acts as a protecting barrier by limiting the effectiveness of conventional antibiotics.

“Since BamA is concerned in important processes for the survival of a variety of Gram-negative pathogens, an optimized peptide antibiotic focusing on this protein may have broad-spectrum exercise, with a possible for a scarcity of cross-resistance to present therapies,” Erin Duffy, PhD, chief of analysis and improvement at CARB-X, mentioned in a press launch.

With the award, CARB-X has now funded 108 early-stage tasks designed to forestall, diagnose, and deal with antibiotic-resistant micro organism.



Source link

Tags: BARDACoviddevelopmentDrugFundpreventive
Previous Post

Trial data support 2 regimens for seasonal malaria prevention in Ugandan children

Next Post

US flu activity still high, with 11 new deaths in kids

Related Posts

‘Helping people survive’: how creating a hip-hop album saved incarcerated artists | Hip-hop
Diseases

‘Helping people survive’: how creating a hip-hop album saved incarcerated artists | Hip-hop

June 4, 2025
Mother’s obesity linked to child’s heightened hospital admission risk for infection
Diseases

Mother’s obesity linked to child’s heightened hospital admission risk for infection

June 4, 2025
Report highlights evidence, remaining data gaps on vaccines and antibiotic resistance
Diseases

Report highlights evidence, remaining data gaps on vaccines and antibiotic resistance

June 3, 2025
MIS-C patients catch up with controls by most measures within 2 years, data suggest
Diseases

MIS-C patients catch up with controls by most measures within 2 years, data suggest

June 4, 2025
U.S. Global Health Legislation Tracker
Diseases

U.S. Global Health Legislation Tracker

June 4, 2025
Large-scale immunity profiling grants insights into flu virus evolution
Diseases

Large-scale immunity profiling grants insights into flu virus evolution

June 3, 2025
Next Post
US flu activity still high, with 11 new deaths in kids

US flu activity still high, with 11 new deaths in kids

Opinion | A Mind at Ease, Away From the Distractions

Opinion | A Mind at Ease, Away From the Distractions

U.S. launches national plan to tackle Parkinson’s disease and related disorders

U.S. launches national plan to tackle Parkinson's disease and related disorders

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Q&A: Building nurses’ trust in AI through education
Health

Q&A: Building nurses’ trust in AI through education

by admin
June 2, 2025
0

Jing Wang, dean of Florida State College’s Faculty of Nursing, sat down with MobiHealthNews to debate the position nurses play...

Hindi oudh #bakhoor #agarwood #chips #market #business #indianoud #wood #wholesaleprice #oudoils #🌍🌎

Hindi oudh #bakhoor #agarwood #chips #market #business #indianoud #wood #wholesaleprice #oudoils #🌍🌎

June 2, 2025
Plastic particles found in food could harm the body

Plastic particles found in food could harm the body

June 1, 2025
Saving Lives and Stopping Super Speeders with Intelligent Speed Assistance Technology

Saving Lives and Stopping Super Speeders with Intelligent Speed Assistance Technology

June 1, 2025
TRR 417 initiative aims to unlock new treatments for colorectal cancer

TRR 417 initiative aims to unlock new treatments for colorectal cancer

May 30, 2025
Walkability Wins: Fourty-Two

Walkability Wins: Fourty-Two

May 31, 2025
Facebook Twitter Instagram Youtube RSS
Agarwood Times

Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.

CATEGORIES

  • Agarwood
  • Diet & Fitness
  • Diseases
  • Health
  • Meditation
  • Nutrition
  • Sleep Info
  • Uncategorized
No Result
View All Result

SITEMAP

  • About us
  • Advertise With Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
VISIT ROYALMOK

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In